Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.50 |
| ▸ | MPL | P40238 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | THRB | P10828 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10785102 | 0.98 | MPL (0.49) | ERN1MPLHPGDHSD17B10LMNA | |
| SCHEMBL6859803 | 0.85 | ERN1 (0.50) | ERN1HPGDHSD17B10ALDH1A1GAA | |
| SCHEMBL28873749 | 0.85 | KDM4E (0.53) | ERN1ALDH1A1GAAKDM4EMEN1 | |
| SCHEMBL1155621 | 0.85 | NPC1 (0.52) | ERN1MPLHPGDLMNAHIF1A | |
| SCHEMBL10785081 | 0.81 | PTGS1 (0.55) | ERN1HPGDHSD17B10ALDH1A1GAA | |
| SCHEMBL9154234 | 0.81 | MPL (0.54) | ERN1MPLHPGDHSD17B10LMNA | |
| SCHEMBL30965843 | 0.81 | L3MBTL1 (0.64) | LMNAALDH1A1GAAMAPTKMT2A | |
| SCHEMBL668653 | 0.81 | L3MBTL1 (0.64) | LMNAALDH1A1GAAMAPTKMT2A | |
| SCHEMBL8300776 | 0.81 | POLB (0.49) | MPLHPGDLMNAALDH1A1GAA | |
| SCHEMBL343614 | 0.80 | CYP3A4 (0.51) | HPGDHSD17B10LMNAHIF1AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2358655-B1 | METHOD FOR PRODUCING PHENOL AND ACETONE | SABIC INNOVATIVE PLASTICS IP (NL) | 2015-05-06 | — | — | EP | claimed |
| US-8030525-B2 | Method for producing phenol and acetone | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2011-10-04 | — | — | US | claimed |
| EP-2358655-A1 | METHOD FOR PRODUCING PHENOL AND ACETONE | SABIC Innovative Plastics IP B.V. (NL) | 2011-08-24 | — | — | EP | claimed |
| US-20100099919-A1 | METHOD FOR PRODUCING PHENOL AND ACETONE | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-04-22 | — | — | US | claimed |
| WO-2010045423-A1 | METHOD FOR PRODUCING PHENOL AND ACETONE | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2010-04-22 | — | — | WO | claimed |
| US-6783913-B2 | POLYMERIC ACETAL RESIN CONTAINS UNITS (A), (B), (C), (D), AND (E). UNIT (A) IS A VINYL ALCOHOL UNIT. UNIT; (B) IS A POLYVINYL ACETAL UNIT CONTAINING AN R GROUP, WHERE R IS HYDROGEN, AN ALIPHATIC GROUP, AN AROMATIC GROUP, OR AN | KODAK POLYCHROME GRAPHICS LLC | 2004-08-31 | — | — | US | claimed |
| US-20030198887-A1 | Polymeric acetal resins containing free radical inhibitors and their use in lithographic printing | EASTMAN KODAK COMPANY | 2003-10-23 | — | — | US | claimed |
| US-4910021-A | Oral administered coated capsule for colonic absorption | R. P. SCHERER CORPORATION (US) | 1990-03-20 | — | — | US | claimed |
| EP-0036534-B1 | AN ORALLY ADMINISTRABLE DRUG FORM COMPRISING A BETA-LACTAM ANTIBIOTIC AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1987-09-23 | — | — | EP | claimed |
| EP-0225189-A2 | Targeted enteral delivery system | R.P. SCHERER CORPORATION (US) | 1987-06-10 | — | — | EP | claimed |
| US-4470980-A | Method of increasing oral absorption of β-lactam antibiotics | INTERX RESEARCH CORP. (US) | 1984-09-11 | — | — | US | claimed |
| US-4406896-A | ANTIBIOTICS, ACIDS, HYDROXY | MERCK & CO., INC. (US) | 1983-09-27 | — | — | US | claimed |
| EP-0036534-A1 | An orally administrable drug form comprising a beta-lactam antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-30 | — | — | EP | claimed |
| EP-0036145-A1 | An orally administered drug form comprising a polar bioactive agent and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-23 | — | — | EP | claimed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | claimed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | claimed |
| CN-117263783-A | Method for preparing acetone by oxidation of isoparaffin | 中国石油大学(华东) | 2023-12-22 | — | — | CN | disclosed |
| CN-117258787-A | Catalyst for preparing acetone by oxidation of isoparaffin and preparation method thereof | 中国石油大学(华东) | 2023-12-22 | — | — | CN | disclosed |
| EP-0035770-A2 | An orally administered drug form comprising a glycosidic antibiotic and an adjuvant | INTERx RESEARCH CORPORATION (US) | 1981-09-16 | — | — | EP | disclosed |
| EP-0031561-A2 | A rectally administered suppository comprising a drug and an adjuvant | MERCK & CO. INC. (US) | 1981-07-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099919-A1 | METHOD FOR PRODUCING PHENOL AND ACETONE | HAO2, AOX1, HPD | ERN1 3107/4885MPL 2034/4885HPGD 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.